Table 4.
Risk factors for HCC recurrence and mortality by multivariate analysis.
| Variables | Before PS Matching | After PS Matching | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | p-Value | OR | 95% CI | p-Value | ||
| HCC recurrence | |||||||
| NLR | 2.973 | 1.436–6.154 | 0.003 | RBC transfusion during operation | 3.920 | 1.030–14.923 | 0.045 |
| ICG-R15 | 1.056 | 1.013–1.101 | 0.009 | ||||
| Portal vein tumor thrombosis | 3.353 | 1.271–8.847 | 0.015 | ||||
| Intrahepatic metastasis | 4.830 | 1.750–13.330 | 0.002 | ||||
| Mortality | |||||||
| Age > 75 | 3.426 | 1.250–9.391 | 0.017 | Age > 75 | 11.333 | 2.471–51.982 | 0.002 |
| Intrahepatic metastasis | 16.463 | 5.948–45.566 | <0.001 | Microvascular invasion | 7.502 | 1.193–47.167 | 0.032 |
| Hospitalization | 1.030 | 1.019–1.042 | <0.001 | Intrahepatic metastasis | 29.092 | 6.627–127.716 | <0.001 |
| AFP > 40 | 3.912 | 1.472–10.395 | 0.006 | RBC transfusion during operation | 13.341 | 2.466–73.266 | 0.003 |
| Hospitalization | 1.044 | 1.026–1.062 | <0.001 | ||||
PS, propensity score; OR, odds ratio; 95% CI, 95% confidence interval; HCC, hepatocellular carcinoma; NLR, neutrophil–lymphocyte ratio; ICG-R15, indocyanine green clearance at 15 min; AFP, alpha-fetoprotein; RBC, red blood cell.